Michael Alekshun

Michael Alekshun is an accomplished executive and inventor renowned for his expertise in Business Development and Licensing (BD&L), Research and Development (R&D), and strategic innovation across healthcare and beauty/cosmetic sectors.

With a diverse background that includes leadership roles in global pharmaceutical, consumer healthcare, and beauty corporations, as well as academia and a venture-funded biotechnology company, Michael boasts a rich tapestry of experience.

His proficiency in Business Development and Licensing encompasses private equity financing, in-licensing/out-licensing activities, and mandated divestments, with a focus on the US, Europe, & Asia.

In the realm of Research and Development, Michael possesses a profound knowledge of small molecules, biologics, and medical devices, having served as a principal investigator on research projects funded by the National Institutes of Health.

Additionally, he has authored scientific publications and patents on critical topics such as antibiotic resistance and new treatment modalities.

Michael's forte lies in Innovation and Strategic Leadership, where he excels in team building, implementing collaborative systems, and spearheading strategic initiatives alongside executive management to tackle innovation challenges creatively.

Beyond his corporate endeavors, Michael has a background in public service, having served as a former elected public official.

His educational journey is marked by accomplishments, including studies at Novartis Corporate Learning, Post-doctorate research at Tufts University School of Medicine, and a Ph.D. from New York Medical College.

He has also augmented his academic credentials with a Certificate from Rutgers Business School and a Bachelor of Science (B.S.) from Pace University-Pleasantville/Briarcliff Campus.

Michael Alekshun currently serves as the Vice President of Business Development at L'Oréal and has formerly held prestigious positions such as Global Head of External Innovation BD&L at Novartis Consumer Health, Director of Licensing and Global Out-licensing & Asset Management at Merck, Schering-Plough, and Director of Anti-infective Drug Discovery at Paratek Pharmaceuticals.